You are here: Industry Insights > UK

News List

Novel antibiotic Recarbrio has launched in the UK pharmatimes
November 20, 2020
MSD’s novel antibiotic treatment Recarbrio has launched in the UK as concerns grow over the rise of antimicrobial resistance (AMR) globally.
US, UK and Germany are top manufacturers for COVID-19 vaccines expresspharma
November 20, 2020
Vaccine developers are selecting manufacturers that are closer to their homes, which could be due to storage or manufacturing availability.
UK strikes deal for five million doses of Moderna’s COVID-19 vaccine pharmatimes
November 18, 2020
The UK government has secured access to five million doses of Moderna’s COVID-19 vaccine after interim data, released yesterday, suggested that the shot is 94.5% effective.
Evotec SE Expands UK Campus contractpharma
November 13, 2020
Evotec SE has expanded its existing campus based at Milton Park in Abingdon, Oxfordshire, UK, into a major, fully-integrated, co-located discovery and development center to be named Dorothy Crowfoot Hodgkin Campus.
UK study will evaluate aspirin as a potential COVID-19 treatment pharmatimes
November 11, 2020
Researchers from the UK’s RECOVERY study will evaluate the standard painkiller aspirin as a potential treatment for COVID-19 patients.
UK and EU agree on phased process for Northern Ireland medicines regulation pharmatimes
November 10, 2020
The UK government and the European Commission (EC) have reached an agreed approach on a phased process for implementing medicines regulation in Northern Ireland following Brexit (31 December).
Oncology development programme launches at UK life science campus pharmatimes
November 06, 2020
A new national oncology development programme is being launched by Bruntwood SciTech at Alderley Park, the UK’s largest single site life science campus.
UK regulator initiates rolling review of AstraZeneca’s vaccine for Covid-19 pharmaceutical-technology
November 04, 2020
UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has initiated the accelerated rolling review of AstraZeneca’s potential vaccine to treat Covid-19.
COVID-19 is threatening the UK’s medical research prowess, say charities europeanpharmaceuticalreview
November 02, 2020
UK government warned the financial impact of the COVID-19 pandemic is threatening the future of UK medical research, as 40 percent of early-career scientists look to leave.
UK biotech consortium identifies COVID-19 antibody combinations pharmatimes
October 30, 2020
The UK BIA Antibody Taskforce, a UK consortium developing antibodies for treating COVID-19, has identified differentiated antibody combinations to take further into development as as an antibody cocktail.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page